Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
6601
6602
6603
6604
6605
6606
6607
6608
6609
6610
6611
6612
6613
6614
6615
6616
6617
6618
6619
6620
6621
6622
6623
6624
6625
6626
6627
6628
6629
6630
6631
6632
6633
6634
6635
6636
6637
6638
6639
6640
6641
6642
6643
6644
6645
6646
6647
6648
6649
6650
6651
6652
6653
6654
6655
6656
6657
6658
6659
6660
6661
6662
6663
6664
6665
6666
6667
6668
6669
6670
6671
6672
6673
6674
6675
6676
6677
6678
6679
6680
6681
6682
6683
6684
6685
6686
6687
6688
6689
6690
6691
6692
6693
6694
6695
6696
6697
6698
6699
6700
6701
6702
6703
6704
6705
6706
6707
6708
6709
6710
6711
6712
6713
6714
6715
6716
6717
6718
6719
6720
6721
6722
6723
6724
6725
6726
6727
6728
6729
6730
6731
6732
6733
6734
6735
6736
6737
6738
6739
6740
6741
6742
6743
6744
6745
6746
6747
6748
6749
6750
6751
6752
6753
6754
6755
6756
6757
6758
6759
6760
6761
6762
6763
6764
6765
6766
6767
6768
6769
6770
6771
6772
6773
6774
6775
6776
6777
6778
6779
6780
6781
6782
6783
6784
6785
6786
6787
6788
6789
6790
6791
6792
6793
6794
6795
6796
6797
6798
6799
6800
| UnnamedSample_HQ_transcript/36629|m.11079 | UnnamedSample_HQ_transcript/36629 | Coverage 0.858 too low. | 11604da27949e0e1fabb320d35225ae4 | 654 | Pfam | PF00012 | Hsp70 protein | 6 | 612 | 9.7E-264 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/36011|m.10935 | UnnamedSample_HQ_transcript/36011 | Coverage 0.949 too low. | 11604da27949e0e1fabb320d35225ae4 | 654 | Pfam | PF00012 | Hsp70 protein | 6 | 612 | 9.7E-264 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/45727|m.13082 | UnnamedSample_HQ_transcript/45727 | Coverage 0.988 too low. | 11604da27949e0e1fabb320d35225ae4 | 654 | Pfam | PF00012 | Hsp70 protein | 6 | 612 | 9.7E-264 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/44386|m.12790 | UnnamedSample_HQ_transcript/44386 | Coverage 0.935 too low. | 11604da27949e0e1fabb320d35225ae4 | 654 | Pfam | PF00012 | Hsp70 protein | 6 | 612 | 9.7E-264 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/89994|m.21255 | UnnamedSample_HQ_transcript/89994 | Coverage 0.447 too low. | 7947bc47893ef1549d3effe161ad995c | 267 | Pfam | PF00501 | AMP-binding enzyme | 4 | 117 | 1.1E-22 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/44498|m.12816 | UnnamedSample_HQ_transcript/44498 | Coverage 0.924 too low. | 93afdab95db1b38ecad5e87cb097443f | 549 | Pfam | PF00364 | Biotin-requiring enzyme | 481 | 548 | 7.8E-19 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/44498|m.12816 | UnnamedSample_HQ_transcript/44498 | Coverage 0.924 too low. | 93afdab95db1b38ecad5e87cb097443f | 549 | Pfam | PF00682 | HMGL-like | 23 | 206 | 2.9E-24 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/44498|m.12816 | UnnamedSample_HQ_transcript/44498 | Coverage 0.924 too low. | 93afdab95db1b38ecad5e87cb097443f | 549 | Pfam | PF02436 | Conserved carboxylase domain | 232 | 430 | 3.0E-69 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/1497|m.851 | UnnamedSample_HQ_transcript/1497 | Coverage 0.879 too low. | 89f161bf63fcf2d574ccf355112a52ce | 920 | Pfam | PF00595 | PDZ domain | 673 | 745 | 2.6E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/1497|m.851 | UnnamedSample_HQ_transcript/1497 | Coverage 0.879 too low. | 89f161bf63fcf2d574ccf355112a52ce | 920 | Pfam | PF00595 | PDZ domain | 298 | 368 | 1.6E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/1497|m.851 | UnnamedSample_HQ_transcript/1497 | Coverage 0.879 too low. | 89f161bf63fcf2d574ccf355112a52ce | 920 | Pfam | PF00595 | PDZ domain | 839 | 911 | 3.0E-11 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/1497|m.851 | UnnamedSample_HQ_transcript/1497 | Coverage 0.879 too low. | 89f161bf63fcf2d574ccf355112a52ce | 920 | Pfam | PF00595 | PDZ domain | 172 | 254 | 2.4E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/1497|m.851 | UnnamedSample_HQ_transcript/1497 | Coverage 0.879 too low. | 89f161bf63fcf2d574ccf355112a52ce | 920 | Pfam | PF00595 | PDZ domain | 477 | 552 | 5.2E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/3961|m.1793 | UnnamedSample_HQ_transcript/3961 | Coverage 0.209 too low. | 0210ef58ca8ceb9038f8fd84ab7fb288 | 1154 | Pfam | PF13246 | Cation transport ATPase (P-type) | 485 | 575 | 4.1E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3961|m.1793 | UnnamedSample_HQ_transcript/3961 | Coverage 0.209 too low. | 0210ef58ca8ceb9038f8fd84ab7fb288 | 1154 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 36 | 96 | 3.6E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3961|m.1793 | UnnamedSample_HQ_transcript/3961 | Coverage 0.209 too low. | 0210ef58ca8ceb9038f8fd84ab7fb288 | 1154 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 822 | 1070 | 2.7E-74 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/14825|m.5360 | UnnamedSample_HQ_transcript/14825 | Identity 0.904 too low. | 892999b82a9d2c3e55d45e609384d3a5 | 988 | Pfam | PF01044 | Vinculin family | 3 | 986 | 0 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/16227|m.5775 | UnnamedSample_HQ_transcript/16227 | Identity 0.900 too low. | 892999b82a9d2c3e55d45e609384d3a5 | 988 | Pfam | PF01044 | Vinculin family | 3 | 986 | 0 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/56683|m.15377 | UnnamedSample_HQ_transcript/56683 | Identity 0.450 too low. | 40cdeb7827398963ee48c68e37e1ee4e | 349 | Pfam | PF00128 | Alpha amylase, catalytic domain | 30 | 338 | 8.1E-84 | T | 22-09-2020 | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF01414 | Delta serrate ligand | 2 | 64 | 1.1E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 367 | 399 | 1.3E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 329 | 358 | 4.5E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 213 | 242 | 2.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 135 | 165 | 4.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 175 | 204 | 1.4E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 251 | 283 | 6.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/50402|m.14101 | UnnamedSample_HQ_transcript/50402 | Coverage 0.979 too low. | 2d953d212ed0e00fec1b6064aba9f7ba | 678 | Pfam | PF00008 | EGF-like domain | 291 | 320 | 4.5E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/95949|m.22081 | UnnamedSample_HQ_transcript/95949 | Coverage 0.895 too low. | c24b8522b8890fdd56e994b6e4471e28 | 298 | Pfam | PF02872 | 5'-nucleotidase, C-terminal domain | 32 | 210 | 4.7E-40 | T | 22-09-2020 | IPR008334 | 5'-Nucleotidase, C-terminal |
| UnnamedSample_HQ_transcript/91192|m.21432 | UnnamedSample_HQ_transcript/91192 | Coverage 0.817 too low. | c24b8522b8890fdd56e994b6e4471e28 | 298 | Pfam | PF02872 | 5'-nucleotidase, C-terminal domain | 32 | 210 | 4.7E-40 | T | 22-09-2020 | IPR008334 | 5'-Nucleotidase, C-terminal |
| UnnamedSample_HQ_transcript/5519|m.2366 | UnnamedSample_HQ_transcript/5519 | Coverage 0.969 too low. | 93fd49b43401a6cead82973ec4482d7d | 1005 | Pfam | PF13620 | Carboxypeptidase regulatory-like domain | 333 | 408 | 2.6E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5519|m.2366 | UnnamedSample_HQ_transcript/5519 | Coverage 0.969 too low. | 93fd49b43401a6cead82973ec4482d7d | 1005 | Pfam | PF13620 | Carboxypeptidase regulatory-like domain | 736 | 812 | 8.9E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5519|m.2366 | UnnamedSample_HQ_transcript/5519 | Coverage 0.969 too low. | 93fd49b43401a6cead82973ec4482d7d | 1005 | Pfam | PF13620 | Carboxypeptidase regulatory-like domain | 823 | 889 | 9.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5519|m.2366 | UnnamedSample_HQ_transcript/5519 | Coverage 0.969 too low. | 93fd49b43401a6cead82973ec4482d7d | 1005 | Pfam | PF00246 | Zinc carboxypeptidase | 46 | 320 | 8.1E-77 | T | 22-09-2020 | IPR000834 | Peptidase M14, carboxypeptidase A |
| UnnamedSample_HQ_transcript/36302|m.11006 | UnnamedSample_HQ_transcript/36302 | Identity 0.933 too low. | 45d240d4749b80fdb5d6a7547fe7f711 | 512 | Pfam | PF09030 | Creb binding | 231 | 305 | 7.7E-18 | T | 22-09-2020 | IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
| UnnamedSample_HQ_transcript/8844|m.3463 | UnnamedSample_HQ_transcript/8844 | Coverage 0.508 too low. | 0f0c771ec316fe321c2ce01a849bf20b | 226 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 72 | 154 | 3.0E-20 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/8639|m.3390 | UnnamedSample_HQ_transcript/8639 | Identity 0.838 too low. | 6504df75430ced46fd4656348daf9a23 | 1235 | Pfam | PF00955 | HCO3- transporter family | 684 | 1186 | 1.2E-195 | T | 22-09-2020 | IPR011531 | Bicarbonate transporter, C-terminal |
| UnnamedSample_HQ_transcript/8639|m.3390 | UnnamedSample_HQ_transcript/8639 | Identity 0.838 too low. | 6504df75430ced46fd4656348daf9a23 | 1235 | Pfam | PF07565 | Band 3 cytoplasmic domain | 350 | 626 | 1.2E-102 | T | 22-09-2020 | IPR013769 | Band 3 cytoplasmic domain |
| UnnamedSample_HQ_transcript/23425|m.7789 | UnnamedSample_HQ_transcript/23425 | Coverage 0.218 too low. | 9752fbb586ed9030d705522458d0a5e6 | 556 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 7 | 422 | 2.8E-12 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/23425|m.7789 | UnnamedSample_HQ_transcript/23425 | Coverage 0.218 too low. | 9752fbb586ed9030d705522458d0a5e6 | 556 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 462 | 552 | 1.1E-10 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/111870|m.24061 | UnnamedSample_HQ_transcript/111870 | Coverage 0.983 too low. | 0ab71401732fa120c5cb2df84a120aeb | 203 | Pfam | PF05383 | La domain | 25 | 81 | 5.3E-20 | T | 22-09-2020 | IPR006630 | La-type HTH domain |
| UnnamedSample_HQ_transcript/30460|m.9574 | UnnamedSample_HQ_transcript/30460 | Identity 0.895 too low. | 2ea1dc4bcb3d9dfa91a17717bd725581 | 723 | Pfam | PF01480 | PWI domain | 1 | 56 | 9.2E-21 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/18954|m.6564 | UnnamedSample_HQ_transcript/18954 | Identity 0.659 too low. | 641963cd7b8aecd566bbea400d8945e1 | 274 | Pfam | PF02781 | Glucose-6-phosphate dehydrogenase, C-terminal domain | 6 | 268 | 3.4E-109 | T | 22-09-2020 | IPR022675 | Glucose-6-phosphate dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/6750|m.2788 | UnnamedSample_HQ_transcript/6750 | Coverage 0.139 too low. | 435d93c4b2014aeafc4b0752b9be476a | 1195 | Pfam | PF00096 | Zinc finger, C2H2 type | 98 | 119 | 6.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6750|m.2788 | UnnamedSample_HQ_transcript/6750 | Coverage 0.139 too low. | 435d93c4b2014aeafc4b0752b9be476a | 1195 | Pfam | PF00096 | Zinc finger, C2H2 type | 59 | 81 | 0.013 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6750|m.2788 | UnnamedSample_HQ_transcript/6750 | Coverage 0.139 too low. | 435d93c4b2014aeafc4b0752b9be476a | 1195 | Pfam | PF00096 | Zinc finger, C2H2 type | 31 | 53 | 0.0018 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6750|m.2788 | UnnamedSample_HQ_transcript/6750 | Coverage 0.139 too low. | 435d93c4b2014aeafc4b0752b9be476a | 1195 | Pfam | PF00096 | Zinc finger, C2H2 type | 738 | 759 | 0.007 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/20633|m.7044 | UnnamedSample_HQ_transcript/20633 | Coverage 0.791 too low. | 1730b592c78de5b7cf8322d49ce665d5 | 1000 | Pfam | PF12455 | Dynein associated protein | 544 | 827 | 1.7E-76 | T | 22-09-2020 | IPR022157 | Dynein associated protein |
| UnnamedSample_HQ_transcript/20633|m.7044 | UnnamedSample_HQ_transcript/20633 | Coverage 0.791 too low. | 1730b592c78de5b7cf8322d49ce665d5 | 1000 | Pfam | PF01302 | CAP-Gly domain | 6 | 70 | 2.3E-23 | T | 22-09-2020 | IPR000938 | CAP Gly-rich domain |
| UnnamedSample_HQ_transcript/76259|m.19072 | UnnamedSample_HQ_transcript/76259 | Coverage 0.859 too low. | 70789ab0d1e5dd2f0b5212733ea74272 | 425 | Pfam | PF00501 | AMP-binding enzyme | 109 | 391 | 3.2E-51 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/84221|m.20375 | UnnamedSample_HQ_transcript/84221 | Coverage 0.954 too low. | 5a77e90ea8126d7b88e4c72b98e3b7c8 | 419 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 58 | 417 | 3.5E-90 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/12160|m.4540 | UnnamedSample_HQ_transcript/12160 | Coverage 0.638 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00650 | CRAL/TRIO domain | 85 | 230 | 1.2E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/12160|m.4540 | UnnamedSample_HQ_transcript/12160 | Coverage 0.638 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00102 | Protein-tyrosine phosphatase | 386 | 632 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/14934|m.5383 | UnnamedSample_HQ_transcript/14934 | Coverage 0.611 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00650 | CRAL/TRIO domain | 85 | 230 | 1.2E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/14934|m.5383 | UnnamedSample_HQ_transcript/14934 | Coverage 0.611 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00102 | Protein-tyrosine phosphatase | 386 | 632 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/18454|m.6434 | UnnamedSample_HQ_transcript/18454 | Identity 0.736 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00650 | CRAL/TRIO domain | 85 | 230 | 1.2E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/18454|m.6434 | UnnamedSample_HQ_transcript/18454 | Identity 0.736 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00102 | Protein-tyrosine phosphatase | 386 | 632 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/8957|m.3501 | UnnamedSample_HQ_transcript/8957 | Coverage 0.661 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00650 | CRAL/TRIO domain | 85 | 230 | 1.2E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/8957|m.3501 | UnnamedSample_HQ_transcript/8957 | Coverage 0.661 too low. | a613bfc8c20505d63a309228ab606afb | 659 | Pfam | PF00102 | Protein-tyrosine phosphatase | 386 | 632 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/75980|m.19017 | UnnamedSample_HQ_transcript/75980 | Coverage 0.874 too low. | e740499c3405e0d2da90ef7ceee64df2 | 494 | Pfam | PF06071 | Protein of unknown function (DUF933) | 302 | 369 | 2.7E-28 | T | 22-09-2020 | IPR013029 | YchF, C-terminal domain |
| UnnamedSample_HQ_transcript/75980|m.19017 | UnnamedSample_HQ_transcript/75980 | Coverage 0.874 too low. | e740499c3405e0d2da90ef7ceee64df2 | 494 | Pfam | PF01926 | 50S ribosome-binding GTPase | 23 | 135 | 2.7E-21 | T | 22-09-2020 | IPR006073 | GTP binding domain |
| UnnamedSample_HQ_transcript/51470|m.14346 | UnnamedSample_HQ_transcript/51470 | Coverage 0.571 too low. | e3dabe4d8ef34dcf3f4880c40271071b | 640 | Pfam | PF09820 | Predicted AAA-ATPase | 49 | 358 | 1.8E-17 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/51893|m.14427 | UnnamedSample_HQ_transcript/51893 | Coverage 0.542 too low. | e3dabe4d8ef34dcf3f4880c40271071b | 640 | Pfam | PF09820 | Predicted AAA-ATPase | 49 | 358 | 1.8E-17 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/121835|m.24982 | UnnamedSample_HQ_transcript/121835 | Coverage 0.751 too low. | 6023d8dab1303f62b201203179368e19 | 114 | Pfam | PF00428 | 60s Acidic ribosomal protein | 16 | 113 | 2.2E-25 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/122824|m.25034 | UnnamedSample_HQ_transcript/122824 | Coverage 0.490 too low. | 6023d8dab1303f62b201203179368e19 | 114 | Pfam | PF00428 | 60s Acidic ribosomal protein | 16 | 113 | 2.2E-25 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/59706|m.15999 | UnnamedSample_HQ_transcript/59706 | Coverage 0.092 too low. | 6679b3ad00cfcf5c1c0f0a22cec23f31 | 524 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 148 | 195 | 5.7E-5 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/59706|m.15999 | UnnamedSample_HQ_transcript/59706 | Coverage 0.092 too low. | 6679b3ad00cfcf5c1c0f0a22cec23f31 | 524 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 243 | 283 | 2.0E-10 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/59706|m.15999 | UnnamedSample_HQ_transcript/59706 | Coverage 0.092 too low. | 6679b3ad00cfcf5c1c0f0a22cec23f31 | 524 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 97 | 145 | 7.5E-10 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/59706|m.15999 | UnnamedSample_HQ_transcript/59706 | Coverage 0.092 too low. | 6679b3ad00cfcf5c1c0f0a22cec23f31 | 524 | Pfam | PF00651 | BTB/POZ domain | 354 | 457 | 7.6E-20 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/107146|m.23479 | UnnamedSample_HQ_transcript/107146 | Identity 0.938 too low. | c9b56976270e1a024e6c771ba8b83f01 | 107 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 2 | 103 | 6.7E-31 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/7411|m.2989 | UnnamedSample_HQ_transcript/7411 | Identity 0.465 too low. | e8f27c8e784ceaee1908fe207b20dff1 | 1273 | Pfam | PF00780 | CNH domain | 966 | 1243 | 1.2E-61 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/7411|m.2989 | UnnamedSample_HQ_transcript/7411 | Identity 0.465 too low. | e8f27c8e784ceaee1908fe207b20dff1 | 1273 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 9.7E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/69227|m.17800 | UnnamedSample_HQ_transcript/69227 | Coverage 0.909 too low. | 7f68f13ab010746ae9c2d319805fa633 | 502 | Pfam | PF01433 | Peptidase family M1 domain | 246 | 475 | 9.5E-33 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/69227|m.17800 | UnnamedSample_HQ_transcript/69227 | Coverage 0.909 too low. | 7f68f13ab010746ae9c2d319805fa633 | 502 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 33 | 210 | 3.6E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/70702|m.18051 | UnnamedSample_HQ_transcript/70702 | Coverage 0.977 too low. | 7f68f13ab010746ae9c2d319805fa633 | 502 | Pfam | PF01433 | Peptidase family M1 domain | 246 | 475 | 9.5E-33 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/70702|m.18051 | UnnamedSample_HQ_transcript/70702 | Coverage 0.977 too low. | 7f68f13ab010746ae9c2d319805fa633 | 502 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 33 | 210 | 3.6E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/47339|m.13435 | UnnamedSample_HQ_transcript/47339 | Coverage 0.237 too low. | 50c0b94c96255902ac73cb546603bc9a | 181 | Pfam | PF00412 | LIM domain | 34 | 91 | 4.5E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/47339|m.13435 | UnnamedSample_HQ_transcript/47339 | Coverage 0.237 too low. | 50c0b94c96255902ac73cb546603bc9a | 181 | Pfam | PF00412 | LIM domain | 98 | 154 | 5.7E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/11685|m.4385 | UnnamedSample_HQ_transcript/11685 | Identity 0.878 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 938 | 1233 | 1.1E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/11685|m.4385 | UnnamedSample_HQ_transcript/11685 | Identity 0.878 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 834 | 891 | 1.9E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/6990|m.2856 | UnnamedSample_HQ_transcript/6990 | Identity 0.892 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 938 | 1233 | 1.1E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/6990|m.2856 | UnnamedSample_HQ_transcript/6990 | Identity 0.892 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 834 | 891 | 1.9E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/4023|m.1812 | UnnamedSample_HQ_transcript/4023 | Coverage 0.953 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 938 | 1233 | 1.1E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/4023|m.1812 | UnnamedSample_HQ_transcript/4023 | Coverage 0.953 too low. | 6a618abb44a3299ed411ab9392804219 | 1234 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 834 | 891 | 1.9E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/13249|m.4880 | UnnamedSample_HQ_transcript/13249 | Coverage 0.309 too low. | 70a5e73bfc3788fba5c63afbaa05af24 | 1223 | Pfam | PF00550 | Phosphopantetheine attachment site | 542 | 602 | 3.9E-14 | T | 22-09-2020 | IPR009081 | Phosphopantetheine binding ACP domain |
| UnnamedSample_HQ_transcript/13249|m.4880 | UnnamedSample_HQ_transcript/13249 | Coverage 0.309 too low. | 70a5e73bfc3788fba5c63afbaa05af24 | 1223 | Pfam | PF00501 | AMP-binding enzyme | 21 | 428 | 2.8E-71 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/13249|m.4880 | UnnamedSample_HQ_transcript/13249 | Coverage 0.309 too low. | 70a5e73bfc3788fba5c63afbaa05af24 | 1223 | Pfam | PF07993 | Male sterility protein | 655 | 889 | 1.1E-52 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/13249|m.4880 | UnnamedSample_HQ_transcript/13249 | Coverage 0.309 too low. | 70a5e73bfc3788fba5c63afbaa05af24 | 1223 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 437 | 512 | 5.5E-7 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/13249|m.4880 | UnnamedSample_HQ_transcript/13249 | Coverage 0.309 too low. | 70a5e73bfc3788fba5c63afbaa05af24 | 1223 | Pfam | PF00106 | short chain dehydrogenase | 1035 | 1221 | 2.8E-49 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/41934|m.12248 | UnnamedSample_HQ_transcript/41934 | Coverage 0.776 too low. | 3425607124cd97b025102bbe03a63b41 | 660 | Pfam | PF09820 | Predicted AAA-ATPase | 38 | 370 | 1.1E-24 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF07776 | Zinc-finger associated domain (zf-AD) | 25 | 99 | 2.5E-10 | T | 22-09-2020 | IPR012934 | Zinc finger, AD-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 456 | 479 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 319 | 341 | 0.0093 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 485 | 507 | 0.0078 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 541 | 563 | 2.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 569 | 591 | 0.0035 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44413|m.12798 | UnnamedSample_HQ_transcript/44413 | Coverage 0.978 too low. | c3d50d6dc8495e06ded20042d1e74565 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 513 | 535 | 0.0064 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/90271|m.21293 | UnnamedSample_HQ_transcript/90271 | Coverage 0.581 too low. | c02c09dfbdd2d80b910999906eb5cef7 | 422 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 258 | 374 | 5.3E-34 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/90271|m.21293 | UnnamedSample_HQ_transcript/90271 | Coverage 0.581 too low. | c02c09dfbdd2d80b910999906eb5cef7 | 422 | Pfam | PF00109 | Beta-ketoacyl synthase, N-terminal domain | 24 | 254 | 8.8E-48 | T | 22-09-2020 | IPR014030 | Beta-ketoacyl synthase, N-terminal |
| UnnamedSample_HQ_transcript/90271|m.21293 | UnnamedSample_HQ_transcript/90271 | Coverage 0.581 too low. | c02c09dfbdd2d80b910999906eb5cef7 | 422 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 377 | 422 | 1.5E-13 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/395|m.305 | UnnamedSample_HQ_transcript/395 | Coverage 0.873 too low. | 3fbd9f23ef9585f47ea43200d4e5e005 | 2240 | Pfam | PF06333 | Mediator complex subunit 13 C-terminal domain | 1799 | 2229 | 2.0E-110 | T | 22-09-2020 | IPR009401 | Mediator complex subunit Med13, C-terminal |
| UnnamedSample_HQ_transcript/395|m.305 | UnnamedSample_HQ_transcript/395 | Coverage 0.873 too low. | 3fbd9f23ef9585f47ea43200d4e5e005 | 2240 | Pfam | PF18296 | MID domain of medPIWI | 1485 | 1761 | 6.9E-71 | T | 22-09-2020 | IPR041285 | MID domain of medPIWI |
| UnnamedSample_HQ_transcript/3547|m.1633 | UnnamedSample_HQ_transcript/3547 | Coverage 0.227 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 48 | 108 | 3.7E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3547|m.1633 | UnnamedSample_HQ_transcript/3547 | Coverage 0.227 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 834 | 1082 | 2.7E-74 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/3547|m.1633 | UnnamedSample_HQ_transcript/3547 | Coverage 0.227 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF13246 | Cation transport ATPase (P-type) | 497 | 587 | 4.2E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3188|m.1520 | UnnamedSample_HQ_transcript/3188 | Coverage 0.245 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF16209 | Phospholipid-translocating ATPase N-terminal | 48 | 108 | 3.7E-25 | T | 22-09-2020 | IPR032631 | P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/3188|m.1520 | UnnamedSample_HQ_transcript/3188 | Coverage 0.245 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 834 | 1082 | 2.7E-74 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/3188|m.1520 | UnnamedSample_HQ_transcript/3188 | Coverage 0.245 too low. | 36c37f0545e061396bf44373d7aca094 | 1166 | Pfam | PF13246 | Cation transport ATPase (P-type) | 497 | 587 | 4.2E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF12738 | twin BRCT domain | 212 | 273 | 3.9E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF12738 | twin BRCT domain | 116 | 175 | 7.9E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF16589 | BRCT domain, a BRCA1 C-terminus domain | 587 | 668 | 2.5E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 1022 | 1087 | 2.9E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 679 | 761 | 3.7E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/11472|m.4319 | UnnamedSample_HQ_transcript/11472 | Coverage 0.650 too low. | b2aa4fd0a67dfa25951e1bc599adbb92 | 1238 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 403 | 477 | 6.8E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/24965|m.8212 | UnnamedSample_HQ_transcript/24965 | Coverage 0.127 too low. | e5f934389aec7c51a332f08b4a786413 | 595 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 299 | 594 | 4.2E-89 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1044 | 1091 | 4.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 3 | 35 | 1.4E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 619 | 667 | 4.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1205 | 1249 | 2.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 758 | 806 | 2.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1152 | 1202 | 3.1E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1252 | 1296 | 3.0E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1299 | 1338 | 4.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 38 | 70 | 3.5E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1094 | 1149 | 1.4E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 1010 | 1034 | 1.6E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00053 | Laminin EGF domain | 710 | 754 | 1.6E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/869|m.574 | UnnamedSample_HQ_transcript/869 | Coverage 0.863 too low. | f1a07a687b9241e94bcf5c0515c06c39 | 1412 | Pfam | PF00052 | Laminin B (Domain IV) | 874 | 1009 | 6.7E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/7608|m.3055 | UnnamedSample_HQ_transcript/7608 | Coverage 0.176 too low. | e371e5727a910ccc22d6b1bf6e77a6b0 | 1396 | Pfam | PF04821 | Timeless protein | 24 | 286 | 4.4E-68 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/7608|m.3055 | UnnamedSample_HQ_transcript/7608 | Coverage 0.176 too low. | e371e5727a910ccc22d6b1bf6e77a6b0 | 1396 | Pfam | PF05029 | Timeless PAB domain | 1002 | 1082 | 8.3E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/36506|m.11050 | UnnamedSample_HQ_transcript/36506 | Identity 0.659 too low. | da1cb883161b2baa7914074873031b16 | 657 | Pfam | PF00650 | CRAL/TRIO domain | 83 | 228 | 1.7E-25 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/36506|m.11050 | UnnamedSample_HQ_transcript/36506 | Identity 0.659 too low. | da1cb883161b2baa7914074873031b16 | 657 | Pfam | PF00102 | Protein-tyrosine phosphatase | 384 | 630 | 1.3E-81 | T | 22-09-2020 | IPR000242 | PTP type protein phosphatase |
| UnnamedSample_HQ_transcript/52543|m.14554 | UnnamedSample_HQ_transcript/52543 | Coverage 0.590 too low. | ee54170f1bf31574558c4072e2605fd4 | 487 | Pfam | PF00069 | Protein kinase domain | 164 | 460 | 7.6E-55 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/50998|m.14246 | UnnamedSample_HQ_transcript/50998 | Coverage 0.597 too low. | ee54170f1bf31574558c4072e2605fd4 | 487 | Pfam | PF00069 | Protein kinase domain | 164 | 460 | 7.6E-55 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/56334|m.15304 | UnnamedSample_HQ_transcript/56334 | Coverage 0.552 too low. | ee54170f1bf31574558c4072e2605fd4 | 487 | Pfam | PF00069 | Protein kinase domain | 164 | 460 | 7.6E-55 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/45271|m.12967 | UnnamedSample_HQ_transcript/45271 | Coverage 0.619 too low. | ee54170f1bf31574558c4072e2605fd4 | 487 | Pfam | PF00069 | Protein kinase domain | 164 | 460 | 7.6E-55 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/15148|m.5444 | UnnamedSample_HQ_transcript/15148 | Coverage 0.905 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/61785|m.16404 | UnnamedSample_HQ_transcript/61785 | Coverage 0.830 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/62717|m.16582 | UnnamedSample_HQ_transcript/62717 | Coverage 0.825 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/35628|m.10846 | UnnamedSample_HQ_transcript/35628 | Coverage 0.878 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/46331|m.13216 | UnnamedSample_HQ_transcript/46331 | Coverage 0.837 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/56297|m.15299 | UnnamedSample_HQ_transcript/56297 | Coverage 0.822 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/66126|m.17238 | UnnamedSample_HQ_transcript/66126 | Coverage 0.811 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/18027|m.6310 | UnnamedSample_HQ_transcript/18027 | Coverage 0.924 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/91465|m.21469 | UnnamedSample_HQ_transcript/91465 | Coverage 0.931 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/81204|m.19918 | UnnamedSample_HQ_transcript/81204 | Coverage 0.762 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/56055|m.15246 | UnnamedSample_HQ_transcript/56055 | Coverage 0.877 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/77978|m.19370 | UnnamedSample_HQ_transcript/77978 | Coverage 0.785 too low. | c4ca8eab2f8832460d600006c3b625d6 | 336 | Pfam | PF00069 | Protein kinase domain | 15 | 233 | 2.2E-25 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/44875|m.12887 | UnnamedSample_HQ_transcript/44875 | Coverage 0.969 too low. | b1b3cb0ba094a41f00d5337e2db07b73 | 374 | Pfam | PF00069 | Protein kinase domain | 46 | 303 | 1.5E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/44875|m.12887 | UnnamedSample_HQ_transcript/44875 | Coverage 0.969 too low. | b1b3cb0ba094a41f00d5337e2db07b73 | 374 | Pfam | PF00433 | Protein kinase C terminal domain | 326 | 366 | 5.9E-10 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/110446|m.23887 | UnnamedSample_HQ_transcript/110446 | Coverage 0.988 too low. | af6feadb1f7d50f865eac40a8fc8e552 | 128 | Pfam | PF00581 | Rhodanese-like domain | 15 | 120 | 2.3E-12 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/21059|m.7158 | UnnamedSample_HQ_transcript/21059 | Coverage 0.912 too low. | 3b6b0d69d9864a2da2f654a774f1e298 | 827 | Pfam | PF11635 | Mediator complex subunit 16 | 126 | 810 | 2.0E-48 | T | 22-09-2020 | IPR021665 | Mediator complex, subunit Med16 |
| UnnamedSample_HQ_transcript/21858|m.7384 | UnnamedSample_HQ_transcript/21858 | Coverage 0.910 too low. | 3b6b0d69d9864a2da2f654a774f1e298 | 827 | Pfam | PF11635 | Mediator complex subunit 16 | 126 | 810 | 2.0E-48 | T | 22-09-2020 | IPR021665 | Mediator complex, subunit Med16 |
| UnnamedSample_HQ_transcript/24278|m.8016 | UnnamedSample_HQ_transcript/24278 | Coverage 0.908 too low. | 3b6b0d69d9864a2da2f654a774f1e298 | 827 | Pfam | PF11635 | Mediator complex subunit 16 | 126 | 810 | 2.0E-48 | T | 22-09-2020 | IPR021665 | Mediator complex, subunit Med16 |
| UnnamedSample_HQ_transcript/46846|m.13333 | UnnamedSample_HQ_transcript/46846 | Coverage 0.276 too low. | 9ef3cb2c30e8cb27f997ead2ad848189 | 475 | Pfam | PF07690 | Major Facilitator Superfamily | 9 | 396 | 7.5E-39 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/27308|m.8792 | UnnamedSample_HQ_transcript/27308 | Coverage 0.926 too low. | f9926513a6463ad282666160f8e00d44 | 211 | Pfam | PF03098 | Animal haem peroxidase | 7 | 196 | 2.8E-49 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/30706|m.9641 | UnnamedSample_HQ_transcript/30706 | Coverage 0.932 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/25369|m.8308 | UnnamedSample_HQ_transcript/25369 | Coverage 0.863 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/15419|m.5527 | UnnamedSample_HQ_transcript/15419 | Coverage 0.118 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/22180|m.7481 | UnnamedSample_HQ_transcript/22180 | Coverage 0.817 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/34167|m.10512 | UnnamedSample_HQ_transcript/34167 | Coverage 0.958 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 529 | 617 | 1.5E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 122 | 204 | 8.1E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 321 | 393 | 3.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 402 | 487 | 3.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 20 | 106 | 2.2E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/27437|m.8819 | UnnamedSample_HQ_transcript/27437 | Coverage 0.883 too low. | 3e4ec1ceae01ff8159664481eac9cabb | 620 | Pfam | PF00630 | Filamin/ABP280 repeat | 215 | 299 | 1.1E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/47067|m.13382 | UnnamedSample_HQ_transcript/47067 | Coverage 0.943 too low. | 0c24fa23d61ff84f9ea5d4e0fbaeacc3 | 513 | Pfam | PF01576 | Myosin tail | 12 | 484 | 8.6E-74 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/16273|m.5789 | UnnamedSample_HQ_transcript/16273 | Coverage 0.950 too low. | d111767fd006fbc2fb9985ca4a97d94b | 529 | Pfam | PF00096 | Zinc finger, C2H2 type | 252 | 275 | 0.014 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/16273|m.5789 | UnnamedSample_HQ_transcript/16273 | Coverage 0.950 too low. | d111767fd006fbc2fb9985ca4a97d94b | 529 | Pfam | PF00096 | Zinc finger, C2H2 type | 465 | 487 | 0.003 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/16273|m.5789 | UnnamedSample_HQ_transcript/16273 | Coverage 0.950 too low. | d111767fd006fbc2fb9985ca4a97d94b | 529 | Pfam | PF00096 | Zinc finger, C2H2 type | 437 | 459 | 0.0061 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/16273|m.5789 | UnnamedSample_HQ_transcript/16273 | Coverage 0.950 too low. | d111767fd006fbc2fb9985ca4a97d94b | 529 | Pfam | PF00096 | Zinc finger, C2H2 type | 285 | 307 | 0.014 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/16273|m.5789 | UnnamedSample_HQ_transcript/16273 | Coverage 0.950 too low. | d111767fd006fbc2fb9985ca4a97d94b | 529 | Pfam | PF00096 | Zinc finger, C2H2 type | 493 | 515 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/72631|m.18407 | UnnamedSample_HQ_transcript/72631 | Identity 0.947 too low. | 16db65495776b107e10228a9b88ffd29 | 532 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 98 | 351 | 3.0E-45 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/22763|m.7636 | UnnamedSample_HQ_transcript/22763 | Coverage 0.524 too low. | 5e7380125cc51b8e42bd5e485def022c | 519 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 143 | 507 | 3.7E-140 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/22763|m.7636 | UnnamedSample_HQ_transcript/22763 | Coverage 0.524 too low. | 5e7380125cc51b8e42bd5e485def022c | 519 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 1 | 143 | 1.5E-63 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
